Cargando…

General health of patients with diabetic macular edema—The LIPSIA study

PURPOSE: Cardiovascular risk factors such as hypertension or dyslipidemia can influence the incidence and progression of diabetic retinopathy (DR) and diabetic macular edema (DME). The aim of this study is to describe the comorbidities in patients with DME. METHODS: Prospective, monocentric observat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Busch, Catharina, Katzmann, Julius L., Jochmann, Claudia, Unterlauft, Jan Darius, Vollhardt, Daniela, Wiedemann, Peter, Laufs, Ulrich, Rehak, Matus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195383/ https://www.ncbi.nlm.nih.gov/pubmed/34115786 http://dx.doi.org/10.1371/journal.pone.0252321

Ejemplares similares

Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment
por: Rehak, Matus, et al.
Publicado: (2019)

Morphology of partial-thickness macular defects: presumed roles of Müller cells and tissue layer interfaces of low mechanical stability
por: Bringmann, Andreas, et al.
Publicado: (2020)

Degenerative lamellar macular holes: tractional development and morphological alterations
por: Bringmann, Andreas, et al.
Publicado: (2021)

GRAding of functional and anatomical response to DExamethasone implant in patients with Diabetic Macular Edema: GRADE-DME Study
por: Rodríguez-Valdés, Patricio J., et al.
Publicado: (2021)

Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study
por: Theilig, Theresa, et al.
Publicado: (2020)

Outcome of a single XEN microstent implant for glaucoma patients with different types of glaucoma
por: Schargus, Marc, et al.
Publicado: (2020)

Different responses of the MIO‑M1 Mueller cell line to angiotensin II under hyperglycemic or hypoxic conditions
por: Beuse, Ansgar, et al.
Publicado: (2023)

Two different populations of Müller cells stabilize the structure of the fovea: an optical coherence tomography study
por: Bringmann, Andreas, et al.
Publicado: (2020)

Functional Monitoring after Trabeculectomy or XEN Microstent Implantation Using Spectral Domain Optical Coherence Tomography and Visual Field Indices—A Retrospective Comparative Cohort Study
por: Schargus, Marc, et al.
Publicado: (2021)

Two Year Functional and Structural Changes—A Comparison between Trabeculectomy and XEN Microstent Implantation Using Spectral Domain Optical Coherence Tomography
por: Bormann, Caroline, et al.
Publicado: (2022)

Refractive Changes after Glaucoma Surgery—A Comparison between Trabeculectomy and XEN Microstent Implantation
por: Bormann, Caroline, et al.
Publicado: (2022)

Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study
por: Busch, Catharina, et al.
Publicado: (2019)

Descemet membrane endothelial keratoplasty (DMEK) improves vision-related quality of life
por: Gellert, Alexandra, et al.
Publicado: (2022)

Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines—A Case Series
por: Girbardt, Christian, et al.
Publicado: (2021)

Analyzing the impact of glaucoma on the macular architecture using spectral-domain optical coherence tomography
por: Unterlauft, Jan D., et al.
Publicado: (2018)

Retinometer predicts visual outcome in Descemet membrane endothelial keratoplasty
por: Wald, Caroline Sophie, et al.
Publicado: (2022)

Why doesn’t high cholesterol hurt?
por: Katzmann, Julius L., et al.
Publicado: (2019)

PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects
por: Katzmann, Julius L., et al.
Publicado: (2020)

Gene Therapy Targeting PCSK9
por: Katzmann, Julius L., et al.
Publicado: (2022)

Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular risk
por: Katzmann, Julius L., et al.
Publicado: (2022)

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
por: Jaissle, Gesine B., et al.
Publicado: (2010)

Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
por: Katzmann, Julius L, et al.
Publicado: (2018)

Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitro
por: Deissler, Heidrun L., et al.
Publicado: (2022)

Diabetic Macular Edema
por: Gundogan, Fatih C., et al.
Publicado: (2016)

Type of culture medium determines properties of cultivated retinal endothelial cells: induction of substantial phenotypic conversion by standard DMEM
por: Busch, Catharina, et al.
Publicado: (2021)

Familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with the apoCIII inhibitor volanesorsen: A case report
por: Tünnemann-Tarr, Adrienn, et al.
Publicado: (2021)

Refractory Diabetic Macular Edema
por: Bainbridge, James
Publicado: (2010)

Corticosteroids for Diabetic Macular Edema
por: Chawan-Saad, Jorge, et al.
Publicado: (2019)

When is macular edema not macular edema? An update on macular telangiectasia type 2
por: Wu, Lihteh
Publicado: (2015)

Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Nontractional Diabetic Macular Edema
por: Ulrich, Jan Niklas
Publicado: (2017)

Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study
por: Katzmann, Julius L., et al.
Publicado: (2020)

Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study
por: Adelman, Ron, et al.
Publicado: (2015)

Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021
por: Katzmann, Julius L., et al.
Publicado: (2022)

Primary treatment of diabetic macular edema
por: Ranchod, Tushar M, et al.
Publicado: (2009)

Emerging Pharmacotherapies for Diabetic Macular Edema
por: Javey, Golnaz, et al.
Publicado: (2012)

Combination Therapy for Diabetic Macular Edema
por: Zur, Dinah, et al.
Publicado: (2012)

Targeting the Pathophysiology of Diabetic Macular Edema
por: Romero-Aroca, Pedro
Publicado: (2010)

Combined Therapy for Diabetic Macular Edema
por: Al Rashaed, Saba, et al.
Publicado: (2013)

Diabetic Macular Edema: Therapeutic Options
por: Kulkarni, Amol D., et al.
Publicado: (2012)

Updates in the Management of Diabetic Macular Edema
por: Mathew, Christopher, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m55g5vua1e6pm296faue9vt5cc